Analysis of Gut Microbiota in Patients with Exacerbated Symptoms of Schizophrenia following Therapy with Amisulpride: A Pilot Study
Evidence is mounting that the gut microbiome is related to the underlying pathogenesis of schizophrenia. However, effects of amisulpride on gut microbiota are poorly defined. This study was aimed at analyzing cytokines and fecal microbiota in patients with exacerbated symptoms of schizophrenia treat...
Saved in:
| Main Authors: | Jinchi Zheng, Zeya Lin, Chih-Yuan Ko, Jian-Hua Xu, Yichuan Lin, Jinyi Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | Behavioural Neurology |
| Online Access: | http://dx.doi.org/10.1155/2022/4262094 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rechallenge with Amisulpride in a Patient with Schizophrenia following a Manic Episode during Previous Therapy
by: Li-Yu Hu, et al.
Published: (2022-01-01) -
Clinical aspects for the treatment of the amisulpride and haloperidol in inpatient treatment of patients with schizophrenia
by: K. S. Altynbekov
Published: (2018-07-01) -
Amisulpride Augmentation for Clozapine-Refractory Positive Symptoms: Additional Benefit in Reducing Hypersialorrhea
by: Fabiani Bogorni, et al.
Published: (2015-01-01) -
The brain-gut microbiota network (BGMN) is correlated with symptom severity and neurocognition in patients with schizophrenia
by: Runlin Peng, et al.
Published: (2025-03-01) -
Detection of Amisulpride Using a Chromium-Salophen Optical Probe
by: Namrata Dhadnekar, et al.
Published: (2024-07-01)